miR-195 inhibits angiogenesis by directly targeting VEGF, Vav guanine nucleotide exchange factor 2 (VAV2), and cell division cycle 42 (CDC42) in HCC cells [151]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.